Published 1997 | Version v1.0.0
Journal Article Open

Pimozide cf. Haloperidol in Tourette Syndrome

Abstract

Pimozide (3.4 mg/day) and haloperidol (3.5 mg/day) therapy for Tourette syndrome were compared in a double-blind, 24-week, placebo-controlled crossover study of 22 patients, aged 7-16 years, at the Institute of Psychiatry, Charleston, SC.

Files

PNB-11-59-c.pdf

Files (2.8 MB)

Name Size Download all
md5:84a050a29286b0ae6931227f2b9a9ea4
2.8 MB Preview Download

Additional details

Identifiers

Other
PNB-11-59-c

Dates

Created
1997
When the item was originally created.